Economic evaluation of prostate cancer screening: a systematic review

被引：8
作者：
Lao, Chunhuan [1 ]
Brown, Charis [1 ]
Rouse, Paul [2 ]
Edlin, Richard [3 ]
Lawrenson, Ross [1 ]
机构：
[1] Univ Auckland, Hamilton, New Zealand
[2] Univ Auckland, Sch Business, Auckland 1, New Zealand
[3] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 03期
关键词：
cost; cost-effectiveness threshold; economic evaluation; prostate cancer; quality of life; screening; ASYMPTOMATIC MEN; COST; ANTIGEN; MORTALITY; PROGRAM; OVERDETECTION; POPULATION; STRATEGIES; VALUES;
D O I：
10.2217/fon.14.273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review, based on published papers, aims to describe the costs of prostate cancer screening and to examine whether prostate cancer screening is cost effective. The estimated cost per cancer detected ranged from Euro1299 in The Netherlands to US$44,355 in the USA. The estimated cost per life-year saved ranged from US$3000 to US$729,000, while the cost per quality-adjusted life year (QALY) was AU$291,817 and Can$371,100. The most appropriate data for economic evaluation of prostate cancer screening should be the cost per QALY gained. The estimated costs per QALY gained by prostate cancer screening were significantly higher than the cost-effectiveness threshold, suggesting that even when based on favorable randomized controlled trials in younger age groups, prostate cancer screening is still not cost effective.
引用
收藏
页码：467 / 477
页数：11
相关论文
共 50 条
[21]   The Cost Implications of Prostate Cancer Screening in the Medicare Population [J].
Ma, Xiaomei ;
Wang, Rong ;
Long, Jessica B. ;
Ross, Joseph S. ;
Soulos, Pamela R. ;
Yu, James B. ;
Makarov, Danil V. ;
Gold, Heather T. ;
Gross, Cary P. .
CANCER, 2014, 120 (01) :96-102
[22]   Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer [J].
Roobol, Monique J. ;
Kranse, Ries ;
Bangma, Chris H. ;
van Leenders, Arno G. J. L. H. ;
Blijenberg, Bert G. ;
van Schaik, Ron H. N. ;
Kirkels, Wim J. ;
Otto, Suzie J. ;
van der Kwast, Theo H. ;
de Koning, Harry J. ;
Schroder, Fritz H. .
EUROPEAN UROLOGY, 2013, 64 (04) :530-539
[23]   Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review [J].
Wang, Tianjiao ;
Bahrampour, Mina ;
Byrnes, Joshua ;
Scuffham, Paul ;
Kirk, Edwin ;
Downes, Martin .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) :197-206
[24]   A scoping review of social relationships and prostate cancer screening [J].
Salmon, Charlotte ;
Parent, Marie-Elise ;
Quesnel-Vallee, Amelie ;
Barnett, Tracie A. .
PREVENTIVE MEDICINE, 2022, 154
[25]   Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials [J].
Anani, Martinez-Gonzalez Nahara ;
Andreas, Plate ;
Oliver, Senn ;
Stefan, Markun ;
Thomas, Rosemann ;
Stefan, Neuner-Jehle .
SWISS MEDICAL WEEKLY, 2018, 148
[26]   Prostate cancer screening: guidelines review and laboratory issues [J].
Filella, Xavier ;
Dolores Albaladejo, Maria ;
Antonio Allue, Juan ;
Angel Castano, Miguel ;
Morell-Garcia, Daniel ;
Angels Ruiz, Maria ;
Santamaria, Maria ;
Jose Torrejon, Maria ;
Gimenez, Nuria .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (10) :1474-1487
[27]   Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population data [J].
Mohammadi, Tima ;
Guh, Daphne P. ;
Tam, Alexander C. T. ;
Pataky, Reka E. ;
Black, Peter C. ;
So, Alan ;
Lynd, Larry D. ;
Zhang, Wei ;
Conklin, Annalijn I. .
CANCER MEDICINE, 2023, 12 (19) :20106-20118
[28]   Prostate Cancer Screening 2010: Updated Recommendations From the American Cancer Society [J].
Brooks, Durado D. ;
Wolf, Andrew M. D. ;
Smith, Robert A. ;
Dash, Chiranjeev ;
Guessous, Idris .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2010, 102 (05) :423-429
[29]   Screening for prostate cancer: an updated review [J].
Marta, Gustavo Nader ;
Hanna, Samir Abdallah ;
Fernandes da Silva, Joao Luis ;
Carvalho, Heloisa de Andrade .
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (01) :101-108
[30]   Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review [J].
Zhang, Zhengchao ;
Tian, Aimin ;
Che, Jizhong ;
Miao, Yandong ;
Liu, Yuanyuan ;
Liu, Yangyang ;
Xu, Yankai .
FRONTIERS IN ONCOLOGY, 2024, 13
12345